Arsenic Poisoning in Pediatric Age
Disclaimer
The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.
Introduction to Pediatric Arsenic Poisoning
Definition: Arsenic poisoning in children represents exposure to toxic inorganic or organic arsenic compounds, leading to multi-system toxicity with both acute and chronic manifestations.
Epidemiology
- Primary sources of exposure:
- Contaminated groundwater
- Industrial pollution
- Agricultural pesticides
- Traditional medicines
- Wood preservatives
- Higher risk in developing countries with contaminated water sources
- Children are particularly vulnerable due to:
- Higher absorption rates
- Immature metabolic pathways
- Hand-to-mouth behavior
- Greater water consumption per body weight
Pathophysiology
- Mechanism of toxicity:
- Inhibition of cellular respiration
- Disruption of ATP production
- Generation of reactive oxygen species
- Interference with DNA repair mechanisms
- Alteration of multiple enzyme systems
- Distribution:
- Rapid absorption through GI tract
- Accumulation in liver, kidneys, heart, and skin
- Crosses blood-brain barrier
- Deposits in hair, nails, and bones
Clinical Presentation
Acute Poisoning
- Gastrointestinal symptoms (onset within hours):
- Severe abdominal pain
- Profuse rice-water diarrhea
- Projectile vomiting
- Hemorrhagic gastroenteritis
- Cardiovascular manifestations:
- Hypotension
- Tachycardia
- QT prolongation
- Ventricular arrhythmias
- Neurological symptoms:
- Encephalopathy
- Seizures
- Delirium
- Coma
Chronic Poisoning
- Dermatological changes:
- Hyperkeratosis
- Hyperpigmentation
- Mees' lines in nails
- Raindrop pigmentation
- Developmental effects:
- Growth retardation
- Cognitive impairment
- Behavioral changes
- Organ system involvement:
- Peripheral neuropathy
- Hepatomegaly
- Chronic lung disease
- Anemia
Diagnosis & Assessment
Initial Evaluation
- History taking:
- Source of exposure
- Duration of exposure
- Environmental assessment
- Family history
- Physical examination:
- Vital signs
- Hydration status
- Neurological assessment
- Skin changes
Laboratory Studies
- Immediate tests:
- Spot urine arsenic level
- 24-hour urine collection
- Complete blood count
- Comprehensive metabolic panel
- Blood gas analysis
- Specialized testing:
- Hair analysis (chronic exposure)
- Nail analysis
- Speciation of arsenic compounds
- Additional studies:
- ECG monitoring
- Chest X-ray
- Abdominal imaging
- Nerve conduction studies (if indicated)
Management
Emergency Management
- Immediate interventions:
- Airway protection
- Fluid resuscitation
- Hemodynamic support
- Seizure control if needed
- Decontamination:
- Removal from exposure source
- Gastric lavage (if indicated)
- Activated charcoal (controversial)
Chelation Therapy
- Indications:
- Acute symptomatic poisoning
- Elevated arsenic levels
- Significant chronic exposure
- Chelating agents:
- Dimercaprol (BAL):
- Dose: 3-5 mg/kg IM q4h
- Duration: 2-10 days
- Succimer (DMSA):
- Dose: 10 mg/kg q8h for 5 days
- Then 10 mg/kg q12h for 14 days
- Dimercaprol (BAL):
Supportive Care
- Fluid and electrolyte management
- Nutritional support
- Pain management
- Treatment of specific complications
Prevention & Monitoring
Prevention Strategies
- Environmental interventions:
- Water testing
- Use of arsenic removal systems
- Safe water alternatives
- Education:
- Family awareness
- Community programs
- Healthcare provider training
Long-term Monitoring
- Regular follow-up:
- Growth monitoring
- Developmental assessment
- Neurological evaluation
- Periodic arsenic level testing
- Complications surveillance:
- Skin cancer screening
- Cardiovascular assessment
- Cognitive function testing
- Quality of life evaluation